Ceramide production mediates aldosterone-induced human umbilical vein endothelial cell (HUVEC) damages

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Zhang, Yumei ^a   Pan, Yu ^a   Bian, Zhixiang ^a   Chen, Peihua ^a   Zhu, Shijian ^a   Gu, Huiyi ^a   Guo, Liping ^a   Hu, Chun ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 DECANOYLAMINO 3 MORPHOLINO 1 PHENYL 1 PROPANOL; ALDOSTERONE; CASPASE 3; CERAMIDE; CERAMIDE SYNTHASE 1; EPLERENONE; MINERALOCORTICOID RECEPTOR; SHORT HAIRPIN RNA; SPHINGOSINE 1 PHOSPHATE; SYNTHETASE; UNCLASSIFIED DRUG; CERS1 PROTEIN, HUMAN; LYSOPHOSPHOLIPID; MEMBRANE PROTEIN; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE; SPHINGOSINE ACYLTRANSFERASE; SPIRONOLACTONE;

APOPTOSIS; ARTICLE; CELL DAMAGE; CELL PROTECTION; CELL STIMULATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; GENE SILENCING; HUMAN; HUMAN CELL; LIPOGENESIS; METABOLIC INHIBITION; METABOLIC REGULATION; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; ANALOGS AND DERIVATIVES; BIOSYNTHESIS; DRUG EFFECTS; GENETICS; METABOLISM; PATHOLOGY;

ALDOSTERONE; CERAMIDES; GENE KNOCKDOWN TECHNIQUES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LYSOPHOSPHOLIPIDS; MEMBRANE PROTEINS; SIGNAL TRANSDUCTION; SPHINGOSINE; SPHINGOSINE N-ACYLTRANSFERASE; SPIRONOLACTONE;

EID: 84958068618     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0146944     Document Type: Article

References (48)

1. Hashikabe Y, Suzuki K, Jojima T, Uchida K, Hattori Y (2006) Aldosterone impairs vascular endothelial cell function. J Cardiovasc Pharmacol 47:609-613. PMID: 16680076
2. Epstein M (2001) Aldosterone as a mediator of progressive renal disease: pathogenetic and clinical implications. Am J Kidney Dis 37:677-688. PMID: 11273866
3. Calhoun DA (2006) Aldosterone and cardiovascular disease: smoke and fire. Circulation 114:2572-2574. PMID: 17159070
4. Hillaert MA, Lentjes EG, Beygui F, Kemperman H, Asselbergs FW, Nathoe HM, et al. (2011) Measuring and targeting aldosterone and renin in atherosclerosis-a review of clinical data. Am Heart J 162:585-596. doi: 10.1016/j.ahj.2011.06.015 PMID: 21982648
5. Keidar S, Kaplan M, Pavlotzky E, Coleman R, Hayek T, Hamoud S, et al. (2004) Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone. Circulation 109:2213-2220. PMID: 15123520
6. Palmer BR, Pilbrow AP, Frampton CM, Yandle TG, Skelton L, Nicholls MG, et al. (2008) Plasma aldosterone levels during hospitalization are predictive of survival post-myocardial infarction. Eur Heart J 29:2489-2496. doi: 10.1093/eurheartj/ehn383 PMID: 18757359
7. Tomaschitz A, Pilz S, Ritz E, Meinitzer A, Boehm BO, Marz W (2010) Plasma aldosterone levels are associated with increased cardiovascular mortality: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Eur Heart J 31:1237-1247. doi: 10.1093/eurheartj/ehq019 PMID: 20200015
8. Vantrimpont P, Rouleau JL, Ciampi A, Harel F, de Champlain J, Bichet D, et al. (1998) Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study. Eur Heart J 19:1552-1563. PMID: 9820995
9. Farquharson CA, Struthers AD (2002) Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy. Clin Sci (Lond) 103:425-431.
10. Lu JP, Li X, Jin YL, Chen MX (2014) Endoplasmic reticulum stress-mediated aldosterone-induced apoptosis in vascular endothelial cells. J Huazhong Univ Sci Technolog Med Sci 34:821-824. doi: 10. 1007/s11596-014-1359-0 PMID: 25480576
11. Qiao W, Zhang W, Shao S, Gai Y, Zhang M (2015) Effect and mechanism of poly (ADP-ribose) polymerase-1 in aldosterone-induced apoptosis. Mol Med Rep 12:1631-1638. doi: 10.3892/mmr.2015. 3596 PMID: 25872931
12. Lin CF, Chen CL, Lin YS (2006) Ceramide in apoptotic signaling and anticancer therapy. Curr Med Chem 13:1609-1616. PMID: 16787207
13. Mullen TD, Obeid LM (2012) Ceramide and apoptosis: exploring the enigmatic connections between sphingolipid metabolism and programmed cell death. Anticancer Agents Med Chem 12:340-363. PMID: 21707511
14. Young MM, Kester M, Wang HG (2013) Sphingolipids: regulators of crosstalk between apoptosis and autophagy. J Lipid Res 54:5-19. doi: 10.1194/jlr. R031278 PMID: 23152582
15. Ogretmen B, Hannun YA (2001) Updates on functions of ceramide in chemotherapy-induced cell death and in multidrug resistance. Drug Resist Updat 4:368-377. PMID: 12030784
16. Reynolds CP, Maurer BJ, Kolesnick RN (2004) Ceramide synthesis and metabolism as a target for cancer therapy. Cancer Lett 206:169-180. PMID: 15013522
17. Wu CH, Cao C, Kim JH, Hsu CH, Wanebo HJ, Bowen WD, et al. (2012) Trojan-horse nanotube on-command intracellular drug delivery. Nano Lett 12:5475-5480. doi: 10.1021/nl301865c PMID: 23030797
18. Huo HZ, Zhou ZY, Wang B, Qin J, Liu WY, Gu Y (2014) Dramatic suppression of colorectal cancer cell growth by the dual mTORC1 and mTORC2 inhibitor AZD-2014. Biochem Biophys Res Commun 443:406-412. doi: 10.1016/j.bbrc.2013.11.099 PMID: 24309100
19. Gong L, Yang B, Xu M, Cheng B, Tang X, Zheng P, et al. (2014) Bortezomib-induced apoptosis in cultured pancreatic cancer cells is associated with ceramide production. Cancer Chemother Pharmacol 73:69-77. doi: 10.1007/s00280-013-2318-3 PMID: 24190701
20. Yao C, Wu S, Li D, Ding H, Wang Z, Yang Y, et al. (2012) Co-administration phenoxodiol with doxorubicin synergistically inhibit the activity of sphingosine kinase-1 (SphK1), a potential oncogene of osteosarcoma, to suppress osteosarcoma cell growth both in vivo and in vitro. Mol Oncol 6:392-404. doi: 10.1016/j.molonc.2012.04.002 PMID: 22583777
21. Hornemann T, Penno A, Rutti MF, Ernst D, Kivrak-Pfiffner F, Rohrer L, et al. (2009) The SPTLC3 subunit of serine palmitoyltransferase generates short chain sphingoid bases. J Biol Chem 284:26322-26330. doi: 10.1074/jbc. M109.023192 PMID: 19648650
22. Kraveka JM, Li L, Bielawski J, Obeid LM, Ogretmen B (2003) Involvement of endogenous ceramide in the inhibition of telomerase activity and induction of morphologic differentiation in response to all-transretinoic acid in human neuroblastoma cells. Arch Biochem Biophys 419:110-119. PMID: 14592454
23. Zecevic A, Menard H, Gurel V, Hagan E, DeCaro R, Zhitkovich A (2009) WRN helicase promotes repair of DNA double-strand breaks caused by aberrant mismatch repair of chromium-DNA adducts. Cell Cycle 8:2769-2778. PMID: 19652551
24. Edmonds Y, Milstien S, Spiegel S (2011) Development of small-molecule inhibitors of sphingosine-1-phosphate signaling. Pharmacol Ther 132:352-360. doi: 10.1016/j.pharmthera.2011.08.004 PMID: 21906625
25. Yao C, Wei JJ, Wang ZY, Ding HM, Li D, Yan SC, et al. (2012) Perifosine Induces Cell Apoptosis in Human Osteosarcoma Cells: New Implication for Osteosarcoma Therapy? Cell Biochem Biophys.
26. Di Raimondo D, Tuttolomondo A, Butta C, Miceli S, Licata G, Pinto A (2012) Effects of ACE-inhibitors and angiotensin receptor blockers on inflammation. Curr Pharm Des 18:4385-4413. PMID: 22283779
27. Ponnusamy S, Meyers-Needham M, Senkal CE, Saddoughi SA, Sentelle D, Selvam SP, et al. (2010) Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance. Future Oncol 6:1603-1624. doi: 10.2217/fon. 10.116 PMID: 21062159
28. Ogretmen B, Hannun YA (2004) Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer 4:604-616. PMID: 15286740
29. Mathias S, Pena LA, Kolesnick RN (1998) Signal transduction of stress via ceramide. Biochem J 335(Pt 3):465-480. PMID: 9794783
30. Brown NJ (2013) Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis. Nat Rev Nephrol 9:459-469. doi: 10.1038/nrneph.2013.110 PMID: 23774812
31. Laragh JH, Baer L, Brunner HR, Buhler FR, Sealey JE, Vaughan ED Jr. (1972) Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. Am J Med 52:633-652. PMID: 4337477
32. Ding W, Yang L, Zhang M, Gu Y (2012) Reactive oxygen species-mediated endoplasmic reticulum stress contributes to aldosterone-induced apoptosis in tubular epithelial cells. Biochem Biophys Res Commun 418:451-456. doi: 10.1016/j.bbrc.2012.01.037 PMID: 22281495
33. Chun TY, Pratt JH (2004) Non-genomic effects of aldosterone: new actions and questions. Trends Endocrinol Metab 15:353-354. PMID: 15380805
34. Patel BM, Mehta AA (2012) Aldosterone and angiotensin: Role in diabetes and cardiovascular diseases. Eur J Pharmacol 697:1-12. doi: 10.1016/j.ejphar.2012.09.034 PMID: 23041273
35. Lai L, Pen A, Hu Y, Ma J, Chen J, Hao CM, et al. (2007) Aldosterone upregulates vascular endothelial growth factor expression in mouse cortical collecting duct epithelial cells through classic mineralocorticoid receptor. Life Sci 81:570-576. PMID: 17655877
36. Yuan Y, Chen Y, Zhang P, Huang S, Zhu C, Ding G, et al. (2012) Mitochondrial dysfunction accounts for aldosterone-induced epithelial-to-mesenchymal transition of renal proximal tubular epithelial cells. Free Radic Biol Med 53:30-43. doi: 10.1016/j.freeradbiomed.2012.03.015 PMID: 22608985
37. Luo Y, Rui HL, Chen YP (2006) [The role of MAPK/ERK1/2 signaling pathway in aldosterone stimulated transforming growth factor-beta1 synthesis in renal tubular epithelial cells]. Zhonghua Yi Xue Za Zhi 86:3133-3137. PMID: 17313766
38. Terada Y, Ueda S, Hamada K, Shimamura Y, Ogata K, Inoue K, et al. (2012) Aldosterone stimulates nuclear factor-kappa B activity and transcription of intercellular adhesion molecule-1 and connective tissue growth factor in rat mesangial cells via serum- and glucocorticoid-inducible protein kinase-1. Clin Exp Nephrol 16:81-88. doi: 10.1007/s10157-011-0498-x PMID: 22042038
39. Maron BA, Zhang YY, White K, Chan SY, Handy DE, Mahoney CE, et al. (2012) Aldosterone inactivates the endothelin-B receptor via a cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterial hypertension. Circulation 126:963-974. doi: 10. 1161/CIRCULATIONAHA.112.094722 PMID: 22787113
40. Toda N, Nakanishi S, Tanabe S (2013) Aldosterone affects blood flow and vascular tone regulated by endothelium-derived NO: therapeutic implications. Br J Pharmacol 168:519-533. doi: 10.1111/j.1476-5381.2012.02194.x PMID: 23190073
41. Veldman RJ, Klappe K, Hoekstra D, Kok JW (1998) Metabolism and apoptotic properties of elevated ceramide in HT29rev cells. Biochem J 331(Pt 2):563-569. PMID: 9531498
42. Babia T, Veldman RJ, Hoekstra D, Kok JW (1998) Modulation of carcinoembryonic antigen release by glucosylceramide-implications for HT29 cell differentiation. Eur J Biochem 258:233-242. PMID: 9851714
43. Bose R, Verheij M, Haimovitz-Friedman A, Scotto K, Fuks Z, Kolesnick R (1995) Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell 82:405-414. PMID: 7634330
44. Jaffrezou JP, Levade T, Bettaieb A, Andrieu N, Bezombes C, Maestre N, et al. (1996) Daunorubicininduced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis. Embo J 15:2417-2424. PMID: 8665849
45. Myrick D, Blackinton D, Klostergaard J, Kouttab N, Maizel A, Wanebo H, et al. (1999) Paclitaxelinduced apoptosis in Jurkat, a leukemic T cell line, is enhanced by ceramide. Leuk Res 23:569-578. PMID: 10374850
46. Yu T, Li J, Qiu Y, Sun H (2011) 1-Phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) facilitates curcumin-induced melanoma cell apoptosis by enhancing ceramide accumulation, JNK activation, and inhibiting PI3K/AKT activation. Mol Cell Biochem 361:47-54. doi: 10.1007/s11010-011-1086-9 PMID: 21959977
47. Dijkhuis AJ, Klappe K, Jacobs S, Kroesen BJ, Kamps W, Sietsma H, et al. (2006) PDMP sensitizes neuroblastoma to paclitaxel by inducing aberrant cell cycle progression leading to hyperploidy. Mol Cancer Ther 5:593-601. PMID: 16546973
48. Sietsma H, Veldman RJ, Kolk D, Ausema B, Nijhof W, Kamps W, et al. (2000) 1-phenyl-2-decanoylamino-3-morpholino-1-propanol chemosensitizes neuroblastoma cells for taxol and vincristine. Clin Cancer Res 6:942-948. PMID: 10741719